Sachetta’s Inovio Pharmaceuticals INO Stock Holding History

Sachetta’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3	Closed	-$2	–	1269
2024 Q1	$2	Buy	+3	New	+$26	﹤0.01%	1149

Other funds holding INO

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Sachetta's INO Position: Q2 2024 in Review

Sachetta sold out of Inovio Pharmaceuticals (INO) in Q2 2024, closing a stake of 3 shares — an estimated $2 sold.

Sachetta first reported a position in INO in Q1 2024 and held it in 1 quarter. The position peaked at $2 in Q1 2024. 96 funds tracked by Wall St. Rank hold INO as of Q2 2024.

Sachetta reported no remaining Inovio Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Sachetta sold 3 Inovio Pharmaceuticals shares in Q2 2024, an estimated $2.
Sachetta first reported a position in Inovio Pharmaceuticals in Q1 2024 and held it in 1 quarter.
Sachetta's Inovio Pharmaceuticals position peaked at $2 in Q1 2024.
96 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2024.

Based on Sachetta's 13F filing for Q2 2024, filed 7 Aug 2024.